Drug profile · INN
aminocaproic acid
AMINOCAPROIC ACID
aminocaproic acid (AMINOCAPROIC ACID) is a tissue-type plasminogen activator inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — aminocaproic acid
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
aminocaproic acid (AMINOCAPROIC ACID) is a tissue-type plasminogen activator inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Tissue-type plasminogen activator inhibitor
Primary target: Plasminogen
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is aminocaproic acid?
aminocaproic acid (AMINOCAPROIC ACID) is a tissue-type plasminogen activator inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for aminocaproic acid?
AMINOCAPROIC ACID is a marketed brand name for aminocaproic acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of aminocaproic acid?
aminocaproic acid has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.